Best TWAS P=1.18e-12 · Best GWAS P=1.51e-33 conditioned to 7.09e-23
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Whole Blood | CD33 | 0.17 | 0.05 | lasso | 3 | 0.01 | 2.2e-02 | 7.0 | 7.0 | 2.3e-12 | -0.58 | 0.15 | 0.42 | FALSE |
2 | YFS | Blood | CD33 | 0.16 | 0.09 | enet | 42 | 0.12 | 1.2e-37 | 7.1 | 5.6 | 1.7e-08 | -0.44 | 1.00 | 0.00 | FALSE |
3 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CD33 | 0.09 | 0.08 | lasso | 2 | 0.09 | 1.0e-17 | 7.0 | 6.9 | 3.9e-12 | -0.58 | 1.00 | 0.00 | FALSE |
4 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SIGLEC14 | 0.30 | 0.15 | enet | 18 | 0.18 | 1.4e-34 | 4.3 | -5.2 | 1.9e-07 | -0.02 | 0.09 | 0.83 | FALSE |
5 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SIGLEC14 | 0.23 | 0.08 | enet | 12 | 0.10 | 1.6e-11 | 4.0 | -5.4 | 7.5e-08 | 0.00 | 0.21 | 0.61 | FALSE |
6 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | CD33 | 0.10 | 0.01 | enet | 18 | 0.06 | 2.0e-04 | 7.0 | 6.1 | 1.1e-09 | -0.55 | 0.08 | 0.24 | FALSE |
7 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SIGLEC5 | 0.12 | 0.00 | lasso | 4 | 0.02 | 3.5e-03 | 4.3 | -5.5 | 4.8e-08 | -0.02 | 0.02 | 0.48 | FALSE |
8 | The Cancer Genome Atlas | Lung Adenocarcinoma | SIGLEC14 | 0.33 | 0.11 | enet | 20 | 0.12 | 6.6e-14 | 4.3 | -5.7 | 1.6e-08 | -0.02 | 0.09 | 0.83 | FALSE |
9 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | CD33 | 0.05 | 0.06 | lasso | 1 | 0.06 | 5.1e-07 | 7.1 | 7.1 | 1.2e-12 | -0.58 | 0.94 | 0.02 | TRUE |
10 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | SIGLEC14 | 0.34 | 0.16 | enet | 11 | 0.18 | 1.4e-20 | 4.3 | -5.4 | 6.4e-08 | -0.02 | 0.09 | 0.83 | FALSE |
11 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CD33 | 0.11 | 0.08 | blup | 55 | 0.09 | 5.2e-10 | 7.1 | 5.3 | 1.0e-07 | -0.34 | 0.88 | 0.12 | FALSE |
12 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SIGLEC14 | 0.17 | 0.05 | lasso | 4 | 0.10 | 6.3e-11 | -4.3 | -5.9 | 4.1e-09 | 0.03 | 0.11 | 0.79 | FALSE |
13 | The Cancer Genome Atlas | Stomach Adenocarcinoma | SIGLEC14 | 0.28 | 0.14 | enet | 14 | 0.17 | 1.4e-12 | 4.3 | -5.3 | 8.8e-08 | -0.01 | 0.10 | 0.83 | FALSE |
14 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | SIGLEC14 | 0.39 | 0.07 | lasso | 6 | 0.07 | 2.1e-03 | 4.3 | -6.0 | 2.4e-09 | -0.01 | 0.01 | 0.33 | TRUE |
15 | The Cancer Genome Atlas | Thyroid Carcinoma | SIGLEC14 | 0.17 | 0.04 | enet | 16 | 0.08 | 4.6e-08 | 4.3 | -5.2 | 2.6e-07 | 0.01 | 0.06 | 0.88 | FALSE |